Skip to content
Sunday 9 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,901.09
+0.31%
DAX
26,319.45
+0.69%
CAC 40
8,714.93
+0.17%
STOXX 50
6,523.86
+0.33%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Monday 22 March 2021 2:34 pm

Test and Trace trials ‘groundbreaking’ new technology to detect Covid mutations

By: Poppy Wood

Add as a preferred source on Google
Testing Surge Planned In North London Area Where P1 'Brazilian' Variant Found

NHS Test and Trace has begun trials of a “groundbreaking” new variant test that can hunt down Covid mutations and return results within 48 hours, the health secretary has announced.

The tests could potentially halve the time it takes to identify whether a positive coronavirus sample contains a variant of concern, which usually take around five days for genomic sequencing.

It means positive cases of Covid mutations will be contacted more quickly, thereby slowing the spread of new variants.

Health secretary Matt Hancock said the genotype assay testing would help “rapidly identify variant cases and trace contacts quicker than ever before, helping stop outbreaks in their tracks and ensuring we can continue to follow the roadmap we have set out to get back to normal life.”

Health minister Lord Bethell added that the new variant tests will “accelerate our knowledge and understanding of variants of concern and halt their spread across the country.”

The Prime Minister’s roadmap for leaving lockdown hinges on various conditions being met, including the threat of new variants being kept at bay.

Ten variants are currently being monitored by the government, four of which were first detected in the UK. They include the Kent Covid variant, which was first identified in September last year and is now Britain’s dominant strain of coronavirus.

Read more

Andy Burnham pressured to safeguard jury trials after legal backlash

Andy Burnham speaking at a press conference, addressing current events and regional developments, wearing a suit and tie.

Research published earlier this month in the British Medical Journal suggested that the Kent mutation may be around 64 per cent more lethal compared to previous Covid variants.

However, the Astrazeneca, Pfizer and Novavax vaccines are all thought to be effective in protecting against the new strain, also known as the B117 variant.

Concerns have now turned to the South Africa variant, after trials of the Astrazeneca vaccine performed by the University of Oxford found it provided only limited protection against mild and moderate disease from the new strain.

More than 300 cases of the South African variant have been identified in the UK so far, alongside 12 of a new Manaus variant, which is thought to be partially resistant to available vaccines.

The government has already introduced several procedures to limit the spread of new Covid mutations, including surge testing, the hotel quarantine scheme and enhanced contact tracing.

Last month’s discovery of six new cases of the Manaus variant, also known as the P1 variant, sparked a nationwide hunt for the individual behind one of the positive tests.

The missing case was eventually traced back to Croydon after a week-long search. The individual had recently travelled back to the UK from Brazil, and had been quarantining with their family at home in London.

Read more

ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Politics
  • Tech

Related Topics

  • Coronavirus
  • Re-lockdown
  • Test and Trace
  • Vaccine

Trending Articles

  • Thames Water faces fresh threat to survival after pensions regulation breach

  • PwC’s Embankment HQ to get major makeover ahead of Canary Wharf move

  • Family feud: London estate agent Winkworth sues chair over plot with wife to oust son from board

  • As it happened: Stocks rise despite new tensions in Strait of Hormuz; Oil price climbs

  • A tribute to wine legend Matthew Jukes by his friend Libby Brodie

More from Morning Wire

  • Andy Burnham pressured to safeguard jury trials after legal backlash

    Legal
    Andy Burnham speaking at a press conference, addressing current events and regional developments, wearing a suit and tie.
  • ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials

    Business Wire
  • Acceldata Brings AI Observability to Its xLake Data Platform

    Business Wire
  • Four Taiwanese Performing Groups Shine at France’s Festival Off Avignon

    Business Wire
  • Verdiva Bio Appoints Cardiometabolic Leader Steve Marso as Chief Medical Officer

    Business Wire
  • Verdiva Bio Initiates Phase 1 Study of VRB-103, a Selective Oral Amylin Peptide Analog With Weekly Dosing Potential

    Business Wire
  • Sweeping job cuts at GSK to fund £400m Cambridge campus

    Pharma
    Modern GSK Cambridge campus buildings with sky bridge, green spaces, and people walking and cycling.
  • Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook